Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.yebeh.2021.108160 http://scihub22266oqcxt.onion/10.1016/j.yebeh.2021.108160 34166950!8216683!34166950     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Epilepsy+Behav 2021 ; 122 (ä): 108160 Nephropedia Template TP {{tp|p=34166950|t=2021. COVID-19 vaccination in patients with epilepsy: First experiences in a German tertiary epilepsy center |pdf=|usr=}}{{34166950}} gab.com Text COVID-19 vaccination in patients with epilepsy: First experiences in a German tertiary epilepsy center JO: Epilepsy Behav http://www.kidney.de/pget.php?&tw=1&pmid=34166950 #FOAvip INTRODUCTION: Due to the high demand for information regarding COVID-19 vaccination in people with epilepsy (PWE), we assessed the symptoms and seizure control of PWE following their COVID-19 vaccination. METHODS: All adult patients who were treated at our center were asked to report on their vaccination status and, if vaccinated, about their experiences following their first COVID-19 vaccination with regard to adverse effects and seizure control. RESULTS: Fifty-four PWE have already received their first vaccination against COVID-19 (27 female, 20% seizure free, 96<% on antiseizure medication) and were included in the study. Two-thirds tolerated the vaccines generally either very well or well. Thirty-three percent reported general vaccination adverse effects. The most frequently reported general adverse effects were, in descending order, headache, fatigue and fever, and shivering. With regard to epilepsy-related adverse effects, one patient reported increased seizure frequency one day after the first COVID-19 vaccination was administered, and one reported the occurrence of a new seizure type. None of the patients reported a status epilepticus or aggravation of preexisting adverse effects. CONCLUSIONS: Our data suggest that vaccination against COVID-19 appears to be well tolerated in PWE, supporting the recommendation of vaccination to PWE. Twit Text FOAVip COVID-19 vaccination in patients with epilepsy: First experiences in a German tertiary epilepsy center ????Epilepsy Behav http://www.kidney.de/pget.php?&tw=1&pmid=34166950 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34166950 #FOAvip English Wikipedia <ref>{{Cite pmid|34166950}}</ref> COVID-19 vaccination in patients with epilepsy: First experiences in a German tertiary epilepsy center #MMPMID34166950 von Wrede R; Pukropski J; Moskau-Hartmann S; Surges R; Baumgartner T Epilepsy Behav 2021[Sep]; 122 (ä): 108160 PMID34166950show ga INTRODUCTION: Due to the high demand for information regarding COVID-19 vaccination in people with epilepsy (PWE), we assessed the symptoms and seizure control of PWE following their COVID-19 vaccination. METHODS: All adult patients who were treated at our center were asked to report on their vaccination status and, if vaccinated, about their experiences following their first COVID-19 vaccination with regard to adverse effects and seizure control. RESULTS: Fifty-four PWE have already received their first vaccination against COVID-19 (27 female, 20% seizure free, 96<% on antiseizure medication) and were included in the study. Two-thirds tolerated the vaccines generally either very well or well. Thirty-three percent reported general vaccination adverse effects. The most frequently reported general adverse effects were, in descending order, headache, fatigue and fever, and shivering. With regard to epilepsy-related adverse effects, one patient reported increased seizure frequency one day after the first COVID-19 vaccination was administered, and one reported the occurrence of a new seizure type. None of the patients reported a status epilepticus or aggravation of preexisting adverse effects. CONCLUSIONS: Our data suggest that vaccination against COVID-19 appears to be well tolerated in PWE, supporting the recommendation of vaccination to PWE. |*COVID-19[MESH] |*Epilepsy[MESH] |Adult[MESH] |COVID-19 Vaccines[MESH] |Female[MESH] |Humans[MESH] |SARS-CoV-2[MESH]COVID-19 vaccination in patients with epilepsy: First experiences in a(epmc).pdf DeepDyve Pubget Overpricing